Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol on diaphragm function in hysteroscopic gynecologic surgery
ChiCTR2500102592Phase 4Not yet recruiting
- Sponsor
- Xi'an People's Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam (2 arms), sponsored by Xi'an People's Hospital. Primary endpoints: Diaphragmatic mobility and Diaphragm thickening fraction. Planned start May 2025; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2500102592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102592.